Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

[Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives].

Gonçalves A, Sabatier R, Charafe-Jauffret E, Gilabert M, Provansal M, Tarpin C, Extra JM, Viens P, Bertucci F.

Bull Cancer. 2013 May;100(5):453-64. doi: 10.1684/bdc.2013.1740. Review. French.

PMID:
23695030
2.

Triple-negative breast cancer: current state of the art.

Rastelli F, Biancanelli S, Falzetta A, Martignetti A, Casi C, Bascioni R, Giustini L, Crispino S.

Tumori. 2010 Nov-Dec;96(6):875-88. Review.

3.

Management of triple negative breast cancer.

Oakman C, Viale G, Di Leo A.

Breast. 2010 Oct;19(5):312-21. doi: 10.1016/j.breast.2010.03.026. Epub 2010 Apr 10. Review.

PMID:
20382530
4.

Characteristics of triple-negative breast cancer.

de Ruijter TC, Veeck J, de Hoon JP, van Engeland M, Tjan-Heijnen VC.

J Cancer Res Clin Oncol. 2011 Feb;137(2):183-92. doi: 10.1007/s00432-010-0957-x. Epub 2010 Nov 11. Review.

5.

Molecularly targeted therapies for metastatic triple-negative breast cancer.

Bayraktar S, Glück S.

Breast Cancer Res Treat. 2013 Feb;138(1):21-35. doi: 10.1007/s10549-013-2421-5. Epub 2013 Jan 29. Review.

PMID:
23358903
6.

[Triple-negative breast carcinoma--rewiev of current literature].

Rubovszky G, Udvarhelyi N, Horváth Z, Láng I, Kásler M.

Magy Onkol. 2010 Dec;54(4):325-35. doi: 10.1556/MOnkol.54.2010.4.6. Review. Hungarian.

7.

Updates in the treatment of basal/triple-negative breast cancer.

Shastry M, Yardley DA.

Curr Opin Obstet Gynecol. 2013 Feb;25(1):40-8. doi: 10.1097/GCO.0b013e32835c1633. Review.

PMID:
23222093
8.

What is triple-negative breast cancer?

Irvin WJ Jr, Carey LA.

Eur J Cancer. 2008 Dec;44(18):2799-805. doi: 10.1016/j.ejca.2008.09.034. Epub 2008 Nov 12. Review.

PMID:
19008097
9.

Triple-negative breast cancer: making the most of a misnomer.

McCarthy N, Mitchell G, Bilous M, Wilcken N, Lindeman GJ.

Asia Pac J Clin Oncol. 2012 Jun;8(2):145-55. doi: 10.1111/j.1743-7563.2012.01533.x. Review.

PMID:
22524573
10.

Directed therapy of subtypes of triple-negative breast cancer.

Carey LA.

Oncologist. 2011;16 Suppl 1:71-8. doi: 10.1634/theoncologist.2011-S1-71.

11.

Triple-negative breast cancer: an unmet medical need.

Hudis CA, Gianni L.

Oncologist. 2011;16 Suppl 1:1-11. doi: 10.1634/theoncologist.2011-S1-01. Review.

12.

Promising therapeutic options in triple-negative breast cancer.

Bilici A, Arslan C, Altundag K.

J BUON. 2012 Apr-Jun;17(2):209-22. Review.

PMID:
22740196
13.

Triple-negative breast cancer: disease entity or title of convenience?

Carey L, Winer E, Viale G, Cameron D, Gianni L.

Nat Rev Clin Oncol. 2010 Dec;7(12):683-92. doi: 10.1038/nrclinonc.2010.154. Epub 2010 Sep 28. Review.

PMID:
20877296
14.

Metastatic triple-negative breast cancer.

Rakha EA, Chan S.

Clin Oncol (R Coll Radiol). 2011 Nov;23(9):587-600. doi: 10.1016/j.clon.2011.03.013. Epub 2011 Apr 23. Review.

PMID:
21524569
15.

Triple negative breast cancer: a brief review of its characteristics and treatment options.

Griffiths CL, Olin JL.

J Pharm Pract. 2012 Jun;25(3):319-23. doi: 10.1177/0897190012442062. Epub 2012 May 2. Review.

PMID:
22551559
16.

Treatment of triple negative breast cancer (TNBC): current options and future perspectives.

De Laurentiis M, Cianniello D, Caputo R, Stanzione B, Arpino G, Cinieri S, Lorusso V, De Placido S.

Cancer Treat Rev. 2010 Nov;36 Suppl 3:S80-6. doi: 10.1016/S0305-7372(10)70025-6. Review.

PMID:
21129616
17.

Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.

Venkitaraman R.

Expert Rev Anticancer Ther. 2010 Feb;10(2):199-207. doi: 10.1586/era.09.189. Review.

PMID:
20131996
18.

Current treatment options in triple negative breast cancer.

Rodler E, Korde L, Gralow J.

Breast Dis. 2010;32(1-2):99-122. doi: 10.3233/BD-2010-0304. Review.

PMID:
21778572
19.

Triple-negative breast cancer: advancements in characterization and treatment approach.

Hurvitz S, Mead M.

Curr Opin Obstet Gynecol. 2016 Feb;28(1):59-69. doi: 10.1097/GCO.0000000000000239. Review.

PMID:
26694831
20.

Clinical trials in triple negative breast cancer.

Reeder-Hayes KE, Carey LA, Sikov WM.

Breast Dis. 2010;32(1-2):123-36. doi: 10.3233/BD-2010-0310. Review.

PMID:
21778571

Supplemental Content

Support Center